ARVEE — Arvee Laboratories (India) Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.03bn
- IN₹1.96bn
- IN₹303.45m
Annual cashflow statement for Arvee Laboratories (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30.9 | 36.4 | 34.5 | 61.7 | 18.6 |
| Depreciation | |||||
| Non-Cash Items | 6.07 | -0.031 | -0.13 | 0.764 | -1.72 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 43.5 | -43.3 | -50.8 | -53.9 | 35.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 103 | 17.1 | 6.81 | 29.3 | 67.1 |
| Capital Expenditures | -22.9 | -22.9 | -23.6 | -14.8 | -25.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -7.99 | 16.9 | 24.2 | 2.26 | -25.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -30.8 | -6.04 | 0.593 | -12.6 | -51.5 |
| Financing Cash Flow Items | -8.91 | -4.92 | -3.15 | -2.86 | -2.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -99.2 | 45.2 | -60.6 | -24.2 | -2.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -26.7 | 56.3 | -53.2 | -7.46 | 13.1 |